123 related articles for article (PubMed ID: 37410712)
21. Protective effect of zinc oxide nanoparticles synthesized using Cassia alata for DSS-induced ulcerative colitis in mice model.
Govindarasu M; Vaiyapuri M; Kim JC
Bioprocess Biosyst Eng; 2024 Jun; ():. PubMed ID: 38942827
[TBL] [Abstract][Full Text] [Related]
22. Copaifera spp. oleoresins and two isolated compounds (ent-kaurenoic and ent-polyalthic acid) inhibit Toxoplasma gondii growth in vitro.
Teixeira SC; de Souza G; Junior JPL; Rosini AM; Martínez AFF; Fernandes TAM; Ambrósio SR; Veneziani RCS; Bastos JK; Martins CHG; Barbosa BF; Ferro EAV
Exp Parasitol; 2024 Jul; 262():108771. PubMed ID: 38723847
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo
Khamesipour F; Razavi SM; Hejazi SH; Ghanadian SM
Food Sci Nutr; 2021 Jan; 9(1):522-531. PubMed ID: 33473313
[No Abstract] [Full Text] [Related]
24. The Effect of Vitamin D3 Alone and Mixed With IFN-γ on Tachyzoites of Toxoplasma gondii (RH Strain) Proliferation and Nitric Oxide (NO) Production in Infected Macrophages of BALB/C Mice.
Ghaffarifar F; Abdolah Pour M; Sharifi Z; Dalimi Asl A; Al-Kawaz E
Iran J Parasitol; 2010 Sep; 5(3):48-56. PubMed ID: 22347255
[TBL] [Abstract][Full Text] [Related]
25.
Olanrewaju JA; Owolabi JO; Awodein IP; Enya JI; Adelodun ST; Olatunji SY; Fabiyi SO
J Exp Pharmacol; 2020; 12():439-446. PubMed ID: 33173355
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Characterization of Naproxen Intercalated Zinc Oxide Stacked Nanosheets for Enhanced Hepatoprotective Potential.
Mughal MS; Akram B; Khan BA; Mughal TA; Sulaiman S; Abd-Elkader OH; Sayed SRM; Ibrahim MAA; Sidky AM
ACS Omega; 2024 May; 9(21):22979-22989. PubMed ID: 38826557
[TBL] [Abstract][Full Text] [Related]
27. Effect of Zinc Oxide Nanoparticles on Liver Functions in Albino Mice.
Al-Ragi MJ; Karieb SS; Fathallah N; Zaïri A
Cureus; 2024 Feb; 16(2):e54822. PubMed ID: 38529423
[TBL] [Abstract][Full Text] [Related]
28. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.
Gattan HS; Fouad SS; Ellisy RA; Elshazly H; El-Kady AM
J Parasit Dis; 2024 Jun; 48(2):370-380. PubMed ID: 38840881
[TBL] [Abstract][Full Text] [Related]
29.
Müller J; Hemphill A
Expert Opin Ther Targets; 2023; 27(4-5):293-304. PubMed ID: 37212443
[TBL] [Abstract][Full Text] [Related]
30. Protective role of biosynthesised zinc oxide nanoparticles on pancreatic beta cells: an in vitro and in vivo approach.
John AD; Ragavee A; Selvaraj AD
IET Nanobiotechnol; 2020 Dec; 14(9):756-760. PubMed ID: 33399105
[TBL] [Abstract][Full Text] [Related]
31. Anti-
Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
Parasitology; 2023 Nov; 150(13):1226-1235. PubMed ID: 37859414
[TBL] [Abstract][Full Text] [Related]
32. The New Pharmaceutical Compositions of Zinc Oxide Nanoparticles and Triterpenoids for the Burn Treatment.
Melnikova N; Vorobyova O; Balakireva A; Malygina D; Solovyeva A; Belyaeva K; Orekhov D; Knyazev A
Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32842689
[TBL] [Abstract][Full Text] [Related]
33. Minireview: Applications of NMR-based metabolomics for the detection and characterisation of toxoplasmosis in felids.
Hunter E; Wilson PB
Anal Sci Adv; 2021 Jun; 2(5-6):295-298. PubMed ID: 38716150
[TBL] [Abstract][Full Text] [Related]
34. Humane Endpoints in Swiss Webster Mice Infected with
Arruda IF; Amendoeira MRR; Bonifácio TF; Raso CNDS; Elidio HDSM; Coelho JWR; da Silva LCCP; Dos Santos IB
Animals (Basel); 2024 Apr; 14(9):. PubMed ID: 38731332
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasmosis: Overview from a One Health perspective.
Djurković-Djaković O; Dupouy-Camet J; Van der Giessen J; Dubey JP
Food Waterborne Parasitol; 2019 Jun; 15():e00054. PubMed ID: 32095624
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive assessment of toxoplasmosis and its dormant impact on psychotic disorders (Review).
Mares AM; Varlam CI; Iliuta FP; Lacau RM; Manea MC
Biomed Rep; 2024 Jun; 20(6):86. PubMed ID: 38665421
[TBL] [Abstract][Full Text] [Related]
37. Phyto- and biochemical study on cape gooseberry (
Aboulthana WM; Omar NI; El-Feky AM; Hassan AK; Hasan EA; Seif M; Youssef AM
Nat Prod Res; 2024 May; ():1-14. PubMed ID: 38795161
[TBL] [Abstract][Full Text] [Related]
38. Development of Neurological Mouse Model for Toxoplasmosis Using
Mokua Mose J; Muchina Kamau D; Kagira JM; Maina N; Ngotho M; Njuguna A; Karanja SM
Patholog Res Int; 2017; 2017():4302459. PubMed ID: 28630781
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.
Itani S; Hamie M; El Jammal R; Abdine W; Doumit M; Charafeddine A; El-Sabban M; Patinote C; Masquefa C; Bonnet PA; Obeid M; El Hajj H
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927503
[No Abstract] [Full Text] [Related]
40. Latent toxoplasmosis and human.
Dalimi A; Abdoli A
Iran J Parasitol; 2012; 7(1):1-17. PubMed ID: 23133466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
